Clinical Trials for Cardiotoxicity

The STOP-MED CTRCD Trial

NCT ID: NCT06183437

The STOP-MED CTRCD Trial is a clinical study that aims to find out whether patients who have recovered from heart problems caused by cancer treatments can safely stop taking their heart medication....

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

NCT ID: NCT03418961

This clinical trial, called S1501, is investigating whether a medication called carvedilol can help prevent heart problems in patients with metastatic HER-2-positive breast cancer. This type of can...

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

NCT ID: NCT06778122

The BREATHS trial is studying whether using a special air filtration system in bedrooms can help reduce inflammation and improve heart health in adult cancer survivors who are at risk for heart pro...

Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study

NCT ID: NCT06897189

This clinical trial is studying the effects of radiation treatment on the heart in patients who are receiving thoracic radiotherapy for solid tumors, such as lung cancer. The goal is to find out if...

Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer

NCT ID: NCT05406635

This clinical trial is studying a new way to monitor heart health in women with HER2-positive breast cancer who are receiving treatment. Typically, doctors use imaging tests to check how well the h...

A Study of Blood Pressure Control During Cancer Treatment

NCT ID: NCT06023576

The PROTECT trial is a clinical study aimed at understanding whether a more intensive approach to controlling high blood pressure during breast cancer treatment is safer and more effective than the...

Dapagliflozin for Prevention of Chemotherapy-Induced Cardiotoxicity: a Randomized Controlled Trial

NCT ID: NCT06888505

This clinical trial is studying whether a medication called Dapagliflozin can help prevent heart problems caused by certain cancer treatments, specifically anthracyclines (like doxorubicin) and tra...

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

NCT ID: NCT03711110

The CARTIER clinical trial is studying how to better protect the hearts of elderly patients with certain types of cancer, such as colon cancer, breast cancer, and lymphoma, while they receive cance...

Hypertension and Arrhythmias in CLL Patients Treated with BTK Inhibitors

NCT ID: NCT06211413

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

NCT ID: NCT05465031

The MAINSTREAM trial is studying whether a medication called sacubitril/valsartan can help prevent heart problems in women with breast cancer who are receiving specific chemotherapy treatments. Bre...

Cardioprotection on Chemotherapy-Induced Cardiotoxicity

NCT ID: NCT06853951

This clinical trial is studying how certain medications can protect the heart from damage caused by chemotherapy. Chemotherapy can sometimes lead to a condition called cardiotoxicity, which harms t...

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

NCT ID: NCT05377320

The PACT trial is a study designed to see if a new tool can help cancer survivors and their heart doctors make better decisions about heart health. This tool, which can be accessed through electron...

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

NCT ID: NCT06699056

This clinical trial is studying a new artificial intelligence (AI) tool that helps doctors assess how well the heart is pumping blood, specifically looking at a measurement called ejection fraction...

Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure

NCT ID: NCT04262830

This clinical trial is focused on understanding how certain cancer treatments, specifically anthracycline chemotherapies like doxorubicin and daunorubicin, can affect the heart in young people. The...

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

NCT ID: NCT06332131

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

NCT ID: NCT05271162

The EMPACT study is a clinical trial that is investigating whether a medication called empagliflozin can help prevent heart damage in cancer patients who are receiving certain types of chemotherapy...

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

NCT ID: NCT05703126

This clinical trial is investigating how to better detect heart problems in patients with acute myeloid leukemia (AML) who are receiving a specific type of chemotherapy called anthracyclines. These...

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated with Chemoradiation Therapy

NCT ID: NCT04305613

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients

NCT ID: NCT06622954

This clinical trial is looking at how a special diet may help prevent heart problems in women with early breast cancer who are receiving a specific type of chemotherapy called anthracycline. The re...

Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study

NCT ID: NCT06595147

The BE-FITTER Study is researching how exercise can help improve heart and muscle health in older women who have survived breast cancer. Some breast cancer treatments, especially certain chemothera...